Project Grant HT9425261E393
Award Date 8/1/26
Completion Date 7/31/29
Dollars Obligated $1.7M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Kansas City, MO 64108, USA
Similar Awards
- Federal Grant Award Summary Children's Research Institute received a $777,659 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period August 1, 2025 through July 31, 2028. The award supports research titled "Use of ProResolution and Restorative Pharmacology Approaches for DMD Therapy," focusing on the development of innovative therapeutic interventions for Duchenne muscular dystrophy (DMD). The...
- Federal Grant Award Summary Children's Hospital Los Angeles received a $1.4 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2026, through August 31, 2029. The award funds research to develop CTSR-enhanced chimeric antigen receptor (CAR) T cells designed to overcome the immunosuppressive tumor microenvironment and improve immunotherapy outcomes for pediatric brain tumors. This three-year...
- Federal Grant Award Summary Children's Hospital Los Angeles received a $1.012 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), awarded September 15, 2026, with performance through September 14, 2030. The award funds the development of an international multi-institutional aqueous humor biorepository designed to support biomarker research in rare ocular cancers. This initiative will establish a centralized biological...
- Federal Project Grant Award Summary Children's Research Institute received a $405,341 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period August 1, 2025 through July 31, 2028. The award supports research utilizing pro-resolution and restorative pharmacology approaches for Duchenne muscular dystrophy (DMD) therapy development. This research initiative advances biomedical innovation in support of the Defense...
- Federal Grant Award Summary Cincinnati Children's Hospital Medical Center received a $910,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to define the contemporary natural history and therapeutics impact on cardiomyopathy in Duchenne muscular dystrophy. The award, effective July 15, 2026, through July 14, 2029, supports research conducted at the awardee's facility in Cincinnati, Ohio. This three-year initiative...
- Federal Grant Award Summary Cincinnati Children's Hospital Medical Center received a $750,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), awarded April 1, 2026, with completion targeted for March 31, 2029. This three-year award supports investigator-initiated research on epigenetic mechanisms that drive triple-negative breast cancer, addressing a disease area relevant to military population health and biomedical...
- Federal Project Grant Award Summary Cincinnati Children's Hospital Medical Center received a $321,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) beginning November 1, 2025 and concluding October 31, 2027. The award supports research investigating microRNA-induced silencing as a treatment target for autism-associated deficits in cortical morphology and behavior. This hypothesis-driven research initiative...
- Federal Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $934,501 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025 through August 31, 2028. The award supports research focused on developing peptide-centric chimeric antigen receptor (CAR) T-cell therapies for neurofibromatosis type 1 (NF1)-associated malignant peripheral nerve sheath tumors...
- Federal Project Grant Award Summary Cincinnati Children's Hospital Medical Center received a $249,999 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded September 15, 2025, with completion scheduled for September 14, 2027. The project, "Assessment of Smoldering Glial Activation in Pediatric-Onset MS by Novel Neuroimaging," will deliver neuroimaging research services and analysis focused on evaluating...
- Federal Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $676,117 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) beginning September 1, 2025, with completion scheduled for August 31, 2029. The research project focuses on expanded GAA-GGA chimeric repeats in Friedreich Ataxia, a rare neurological genetic disorder. This award supports biomedical research aimed at advancing medical...